Aggressive hypertension management in patients of advancing and advanced age

Southern Medical Journal

Volumn 98, Issue 8, 2005, Pages 805-808

  Leeper, Stephanie C ^a,b  

^a East Tennessee State University   (United States)

^b TTUHSC   (United States)

Author keywords

Aging; Antihypertensive therapy; Hypertension; Isolated systolic hypertension; J curve

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDAPAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; THIAZIDE DIURETIC AGENT; TORASEMIDE;

AGED; AGING; ANTIHYPERTENSIVE THERAPY; HUMAN; HYPERTENSION; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; PULSE PRESSURE; REVIEW; SYSTOLIC HYPERTENSION; UNITED STATES;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; DRUG MONITORING; GERIATRIC ASSESSMENT; HUMANS; HYPERTENSION;

EID: 24144492664     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200508000-00014     Document Type: Review

References (24)

1. Kaplon NM. Clinical Hypertension. Baltimore, Williams & Wilkins, 1986:2.
2. Castelli WP. Epidemiology of coronary heart disease: the Framingham study. Am J Med 1984;76:4.
3. Neaton JD, Wentworth D, Sherwin R, et al. Comparison of 10 year coronary and cerebrovascular disease mortality rates by hypertensive status for black and non-black men screened in the Multiple Risk Factor Intervention Trial (MRFIT). Circulation 1989;80 (suppl 2):II300.
4. The sixth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC VI). Arch Intern Med 1997;157:2413-2414.
5. The seventh report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. The JNC Report. JAMA 2003;289:2560-2572.
6. Hall WD, Ferrario CM, Moore MA, et al. Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci 1997;313:195-206.
7. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality. Lancet 2002;360:1903-1913.
8. Neal B, MacMahon N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration Lancet: 2000;356:1955-64.
9. Wong J, Wong S. Evidence-based care for the elderly with isolated systolic hypertension. Nurs Health Sci 2005 1:67-75.
10. Major cardiovascular events in hypertensive patients randomized to doxazosin vs. chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA 2000;283:1967-1975.
11. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.
12. Staessen JA, Fagard R, Thijs L. et al, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-764.
13. Liu L, Wang JG, Gong L, et al. for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo for older patients with isolated systolic hypertension. J Hypertens 1998;16:1823-1829.
14. Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.
15. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infraction associated with antihypertensive drug therapies. JAMA 1995;274:620-625.
16. Cruickshank J. The J-curve in hypertension. Curr Cardiol Rep 2003;5:441-452.
17. Hansson L. Treatment of hypertension and the J curve. J Clin Hypertens 1999;1:136-140.
18. Kaplan N. J-curve not burned off by HOT study. Hypertension Optimal Treatment. Lancet 1998;351:1748-1749.
19. Simon G, Chesler E. Understanding and managing isolated systolic hypertension in the elderly. Am J Geriatr Cardiol 1998;7:35-39.
20. Verdecchia P. Prognostic value of ambulatory blood pressure. Hypertension 2000;35:844-851.
21. Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004;291:1342-1349.
22. Glaab T, Weiss T. Use of beta blockers in cardiovascular disease and bronchial asthma/COPD. Internist 2004;45:221-227.
23. Johnson A. NSAIDs and increased blood pressure. Drug Safety 1997;17:277-289.
24. Polonia J. Interaction of antihypertensive drugs with anti-inflammatory drugs. Cardiology 1997;88(suppl. 3):47-51.